Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection

Immunology

Volumn 97, Issue 3, 1999, Pages 474-480

  Kang, B Y ^a   Chung, S W ^a   Lim, Y S ^a   Kim, E J ^a   Kim, S H ^a   Hwang, S Y ^b   Kim, T S ^a  

^a Chonnam National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXICITY; FIBROBLAST; GROWTH INHIBITION; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; INFECTION PREVENTION; INFECTION RESISTANCE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FIBROBLASTS; IMMUNIZATION; INTERLEUKIN-12; LUNG; MICE; MICE, INBRED BALB C; NITRIC OXIDE; RECOMBINANT PROTEINS; TH1 CELLS; TUBERCULOSIS;

EID: 0033048720     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00796.x     Document Type: Article

References (35)

1. 1. CHAISSON R.E., GALLANT J.E., KERULY J.C. & MOORE R.D. (1998) Impact of opportunistic disease on survival in patients with HIV infection. AIDS 12, 29.
2. 2. COOPER A.M., DALTON D.K., STEWART T.A., GRIFFIN J.P., RUSSELL D.G. & ORME I.M. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178, 2243.
3. 3. DORMAN S.E. & HOLLAND S.M. (1998) Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invent 101, 2364.
4. 4. TRINCHIERI G, (1998) Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 16, 365.
5. 5. SJOLANDER A., BALDWIN T.M., CURTIS J.M. & HANDMAN E. (1998) Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J Immunol 160, 3949.
6. + T cells through IL-12-produced by Listeria-induced macrophages. Science 260, 547.
7. 7. KOBAYASHI K., YAMAZAKI J., KASAMA T. et al. (1996) Interleukin(IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy. J Infect Dis 174, 564.
8. 8. YAMAMURA M., UYEMURA K., DEANS R.J. et al. (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254, 277.
9. 9. SCOTT P. & KAUFMANN S.H.E. (1991) The role of T cell subsets and cytokines in the regulation of infection. Immunol Today 12, 346.
10. 10. WYNN T.A., ELTOU I., OSWALD I.P., CHEEVER A.W. & SHER A. (1994) Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179, 1551.
11. 11. GAZZINELLI R.T., WYSOCKA M., HAYASHI S. et al. (1994) Parasite-induced IL-12 stimulates carly IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153, 2533.
12. + T cells. J Immunol 156, 1458.
13. 13. COOPER A.M., MAGRAM J., FERRANTE J. & ORME I.M. (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186, 39.
14. 14. AFONSO L.C., SCHARTON T.M., VIEIRA L.Q., MYSOCKA M., TRINCHIERI G. & SCOTT P. (1994) The adjuvant effect of IL-12 in a vaccine against Leishmania major. Science 263, 235.
15. 15. REMPEL, J.D., WANG M. & HAYGLASS K. T. (1997) In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production. J Immunol 159, 1490.
16. 16. CHOUGNET C. & SHEARER G.M. (1996) Potential clinical applications of inlerleukin-12. Curr Opin Hematol 3, 216.
17. 17. MOTZER R.J., RAKHIT A., SCHWARTZ L.H, et al. (1998) Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma, Clin Cancer Res 4, 1183.
18. 18. GILBOA E. (1996) Immunotherapy of cancer with genetically modified tumor vaccines. Semin Oncol 23, 101.
19. 19. KIM T.S. & COHEN E.P. (1994) Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma. Cancer Res 54, 2531.
20. 20. KIM T.S., XU W.S., SUN T. & COHEN E.P. (1995) Treatment with interleukin-2/interferon-γ double cytokine-secreling allogeneic fibroblasts prolongs the survival of mice with melanoma. Melanoma Res 5, 217.
21. 21. TAHARA H., ZEH III H.J., STORKUS W.J. et al. (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 54, 182.
22. 22. BERTRAM M.A., INTERLIED C.B., YADEGAR S., KOLANOSKI P., YAMADA J.K. & YOUNG L.S. (1986) Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis 154, 194.
23. 23. SAUNDERS B.M., ZHAN Y. & CHEERS C. (1995) Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect Immun 63, 4011.
24. 24. OPENSHAW P., MURPHY E., HOSKEN N.A. et al. (1995) Heterogenicity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and helper 2 populations. J Exp Med 182, 1357.
25. 25. KIM T.S, DEKYUYFF R.H., RUPPER R., MAECKER H.T., LEVY S. & UMETSU D.T. (1997) An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 158, 4137.
26. 26. COLIGAN J.E., KRUISBECK A.M., MARGULIES D.H., SHEVACH E.M. & STROBER W. (1995) Current Protocols in Immunology, Wiley Press, London.
27. 27. FORTIER A.H., POLSINELLI T., GREEN S.J, & NACY C.A. (1992) Activation of macrophages for destruction of Francisella tularensis: identification of cylokines, effector cells, and effector molecules. Infect Immun 60, 817.
28. 28. KIM T.S. & COHEN E.P, (1994) Immunization of mice with allogeneic fibroblasts genetically modified for IL-2-secretion and the expression of melanoma-associated antigens stimulates predetermined classes of antimelanoma effector cells. J Immunother 16, 24.
29. 29. BERMUDEZ L.E. (1993) Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol 91, 277.
30. 30. KOBAYASHI K., NAKATA N., KAI M., KASAMA T., HANYUDA Y. & HATANO Y. (1997) Decreased expression of cylokines that induced type 1 helper T cell/interferon-gamma responses in genetically susceptible mice infected with Mycobacterium avium. Clin Immunol Immunopathol 85, 112.
31. 31. TRIPP C.S., GATELY M.K., KAKIMI J., LING P. & UNANUE E.R. (1994) Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol 152, 1883.
32. 32. KHAN I.A., MATSUURA T. & KASPER L.H. (1994) Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 139, 767.
33. 33. ZHANN Y. & CHEERS C. (1995) Endogenous interleukin-12 (IL-12) is involved in the resistance to Brucella abortus infection. Infect Immun 61, 1387.
34. 34. NABORS G.S., AFONSO L.C.C., FARRELL J.P. & SCOTT P. (1995) Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci USA 92, 3142.
35. 35. ZITVOGEL L., TAHARA H., ROBBINS P.D. et al. (1995) Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J Immunol 155, 1393.